Vosevi (sofosbuvir/velpatasvir/voxilaprevir tablets - Gilead) — Cigna
Patient Has Been Started on Vosevi (continuation of therapy)
Initial criteria
- Patient has been started on Vosevi
- Indication or condition is one addressed as an approval in the Recommended Authorization Criteria section (FDA-Approved Indications or Other Uses with Supportive Evidence)
- Approve remaining duration required to complete a full treatment course (e.g., total of 12 weeks)
Approval duration
remainder of 12-week course